CARLOMAGNO, FRANCESCA

CARLOMAGNO, FRANCESCA  

DIPARTIMENTO DI MEDICINA MOLECOLARE E BIOTECNOLOGIE MEDICHE  

Mostra records
Risultati 1 - 20 di 108 (tempo di esecuzione: 0.194 secondi).
Titolo Tipologia Data di pubblicazione Autore(i) File
Cloning of the rat tissue inhibitor of metalloproteinases type 2 (TIMP-2) gene: analysis of its expression in normal and transformed thyroid cells. 1.1 Articolo in rivista 1994 Santoro, Massimo; C., Battaglia; L., Zhang; Carlomagno, Francesca; M. L., Martelli; Salvatore, Domenico; Fusco, Alfredo
The Human Eps15 gene encoding a tyrosine kinase substrate is conserved in evolution and map to 1p31-1p32 1.1 Articolo in rivista 1994 Wong, Wt; Kraus, Mh; Carlomagno, Francesca; Zelano, A; Druck, T; Croce, Cm; Heubener, K; DI FIORE, Pp
Therapeutic strategies to target the receptor tyrosine kinase AXL in thyroid cancer 4.2 Abstract in Atti di convegno 2012 Gnanaprakasam, Krisnamoorthy; Guida, Teresa; Visciano, Carla; Liotti, Federica; Carlomagno, Francesca; Melillo, ROSA MARINA
Attacking cancer with molecularly targeted agents 1.1 Articolo in rivista 2013 Santoro, Massimo; Carlomagno, Francesca
Antitumor effects of ZD6474, a small molecule vascular endothelial growth factor receptor tyrosine kinase inhibitor, with additional activity against epidermal growth factor receptor tyrosine kinase. 1.1 Articolo in rivista 2003 Fortunato, Ciardiello; Rosa, Caputo; Vincenzo, Damiano; Roberta, Caputo; Teresa, Troiani; Donatella, Vitagliano; Carlomagno, Francesca; Veneziani, BIANCA MARIA; Gabriella, Fontanini; A., Raffaele Bianco; Giampaolo, Tortora
Thyroid cancer in 2010: A roadmap for targeted therapies 1.1 Articolo in rivista 2011 Carlomagno, Francesca; Santoro, Massimo
Ponatinib (AP24534) is a novel potent inhibitor of oncogenic RET mutants associated with thyroid cancer. 1.1 Articolo in rivista 2013 De Falco, V; Buonocore, Preziosa; Muthu, M; Torregrossa, L; Basolo, F; Billaud, M; Gozgit, Jm; Carlomagno, Francesca; Santoro, Massimo
Receptor tyrosine kinase inhibitors in thyroid cancer. 1.1 Articolo in rivista 2008 Castellone, Md; Carlomagno, Francesca; Salvatore, G; Santoro, Massimo
Oncogenic rearrangements driving ionizing radiation-associated human cancer 1.1 Articolo in rivista 2013 Santoro, Massimo; Carlomagno, Francesca
Different mutations of the RET gene cause different human tumoral diseases. 1.1 Articolo in rivista 1999 Santoro, Massimo; Melillo, ROSA MARINA; Carlomagno, Francesca; R., Visconti; DE VITA, Gabriella; G., Salvatore; Fusco, Alfredo; Vecchio, Giancarlo
The extent of linkage disequilibrium in four populations with distinct demographic histories 1.1 Articolo in rivista 2000 Dunning, Am; Durocher, F; Healey, Cs; Teare, Md; Mcbride, Se; Carlomagno, Francesca; Xu, Cf; Dawson, E; Rhodes, S; Ueda, S; Lai, E; Luben, Rn; VAN RENSBURG, Ej; Mannermaa, A; Kataja, V; Rennart, G; Dunhami, ; Purvis, I; Easton, D; Ponder, Ba
Protein kinase Calpha activation by RET: evidence for a negative feedback mechanism controlling RET tyrosine kinase 1.1 Articolo in rivista 2003 Melillo, ROSA MARINA; Carlomagno, Francesca; Oriente, F; Miele, C; Fiory, Francesca; Santopietro, S; Castellone, Md; Beguinot, F; Santoro, Massimo; Formisano, Pietro
Evolutionary conservation of the Eps8 gene and its mapping to human-chromosome 12q23-q24 1.1 Articolo in rivista 1994 Wong, Wt; Carlomagno, Francesca; Druck, T; Barletta, C; Croce, Cm; Heubner, K; Kraus, Mh; DI FIORE, Pp
Molecular biology of the MEN2 gene 1.1 Articolo in rivista 1998 Santoro, M; Melillo, ROSA MARINA; Carlomagno, Francesca; Visconti, R; DE VITA, Gabriella; Salvatore, G; Lupoli, G; Fusco, Alfredo; Vecchio, G.
Only the substitution of methionine 918 with a threonine and not with other residues activates RET transforming potential 1.1 Articolo in rivista 1997 Cirafici, Am; Salvatore, G; DE VITA, G; Carlomagno, Francesca; Dathan, Na; Visonti, R; Melillo, ROSA MARINA; Fusco, Alfredo; Santoro, M.
Comparison of DNA repair protein expression and activities between human fibroblast cell lines with different radiosensitivities 1.1 Articolo in rivista 2000 Carlomagno, Francesca; Burnet, Nj; Turesson, I; Nyman, J; Peacock, Jh; Dunning, Am; Ponder, Baj; Jackson, Sp
Ret-mediated mitogenesis requires Src kinase activity 1.1 Articolo in rivista 1999 Melillo, ROSA MARINA; Barone, Mv; Lupoli, G; Cirafici, Am; Carlomagno, Francesca; Visconti, R; Matoskova, B; DI FIORE, Pp; Vecchio, G; Fusco, Alfredo; Santoro, M.
Mutations in the extracellular domain cause RET loss of function by a dominant negative mechanism 1.1 Articolo in rivista 1998 Cosma, Mp; Cardone, M; Carlomagno, Francesca; Colantuoni, V.
Determination of the frequency of the common 657Del5 Nijmegen breakage syndrome mutation in the German population: no association with risk of breast cancer 1.1 Articolo in rivista 1999 Carlomagno, Francesca; CHANG CLAUDE, J; Dunning, Am; Ponder, Baj
Tyrosine 1062 of RET-MEN2A mediates activation of Akt (protein kinase B) and mitogen-activated protein kinase pathways leading to PC12 cell survival 1.1 Articolo in rivista 2000 DE VITA, Gabriella; Melillo, ROSA MARINA; Carlomagno, Francesca; Visconti, R; Castellone, Md; Bellacosa, A; Billaud, M; Fusco, Alfredo; Tsichlis, Pn; Santoro, M.